The KCA’s International Kidney Cancer Symposium took place on November 15-16 in Miami, Florida. Here are a few of the highlights from the program.
Think Tank: Coalition for a Cure
The KCA convened it’s very first think tank prior to IKCS on November 14. Twenty-five of the top minds in kidney cancer from around the world covering five different specialties – medical oncology, urology, basic science, pharmaceutical industry, and patient advocacy – gathered to discuss the state of kidney cancer research and care and what immediate- and long-term goals were most critical to aim for. The discussion resulted in a list of key areas where researchers should focus their efforts:
• Long-lasting response to treatment/cure
• Screenings and small renal masses
• Surveillance for neo-adjuvant and adjuvant treatment
• Immunotherapy in refractory (unresponsive) renal cell carcinoma
• Non-clear cell renal cell carcinoma
The KCA will publish a white paper detailing the discussion and results with the aim to help guide others in the kidney cancer community with their research efforts.
Eugene P. Schonfeld Award
Dr. W. Kimryn Rathmell, a professor and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), was the first woman to receive the prestigious Eugene P. Schonfeld award, which is granted by the IKCS Scientific Program Committee to recognize respected health care professionals who have made significant contributions in the treatment of renal cell carcinoma. Read more about Dr. Rathmell and the award.
Deb Maskens, kidney cancer survivor, advocate, and co-founder of Kidney Cancer Canada, presented results of a global patient survey.
Read more articles about the research presented at IKCS at…
Watch presentations from IKCS at the KCA’s channel on OncologyTube.